Literature DB >> 22628375

Role of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brain.

Sophocles Chrissobolis1, Botond Banfi, Christopher G Sobey, Frank M Faraci.   

Abstract

Angiotensin II (Ang II) promotes vascular disease through several mechanisms including by producing oxidative stress and endothelial dysfunction. Although multiple potential sources of reactive oxygen species exist, the relative importance of each is unclear, particularly in individual vascular beds. In these experiments, we examined the role of NADPH oxidase (Nox1 and Nox2) in Ang II-induced endothelial dysfunction in the cerebral circulation. Treatment with Ang II (1.4 mg·kg(-1)·day(-1) for 7 days), but not vehicle, increased blood pressure in all groups. In wild-type (WT; C57Bl/6) mice, Ang II reduced dilation of the basilar artery to the endothelium-dependent agonist acetylcholine compared with vehicle but had no effect on responses in Nox2-deficient (Nox2(-/y)) mice. Ang II impaired responses to acetylcholine in Nox1 WT (Nox1(+/y)) and caused a small reduction in responses to acetylcholine in Nox1-deficient (Nox1(-/y)) mice. Ang II did not impair responses to the endothelium-independent agonists nitroprusside or papaverine in either group. In WT mice, Ang II increased basal and phorbol-dibutyrate-stimulated superoxide production in the cerebrovasculature, and these increases were abolished in Nox2(-/y) mice. Overall, these data suggest that Nox2 plays a relatively prominent role in mediating Ang II-induced oxidative stress and cerebral endothelial dysfunction, with a minor role for Nox1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22628375      PMCID: PMC3774474          DOI: 10.1152/japplphysiol.00455.2012

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  38 in total

1.  The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension.

Authors:  Carmen Capone; Giuseppe Faraco; Laibaik Park; Xian Cao; Robin L Davisson; Costantino Iadecola
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-22       Impact factor: 4.733

Review 2.  Protecting against vascular disease in brain.

Authors:  Frank M Faraci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

3.  Hypertension and longitudinal changes in cerebral blood flow: the SMART-MR study.

Authors:  Majon Muller; Yolanda van der Graaf; Frank L Visseren; Willem P Th M Mali; Mirjam I Geerlings
Journal:  Ann Neurol       Date:  2012-03-23       Impact factor: 10.422

Review 4.  Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.

Authors:  Grant R Drummond; Stavros Selemidis; Kathy K Griendling; Christopher G Sobey
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

5.  Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice.

Authors:  Kuniharu Matsuno; Hiroyuki Yamada; Kazumi Iwata; Denan Jin; Masato Katsuyama; Masato Matsuki; Shinji Takai; Kiyofumi Yamanishi; Mizuo Miyazaki; Hiroaki Matsubara; Chihiro Yabe-Nishimura
Journal:  Circulation       Date:  2005-10-25       Impact factor: 29.690

6.  Sex differences in protection against angiotensin II-induced endothelial dysfunction by manganese superoxide dismutase in the cerebral circulation.

Authors:  Sophocles Chrissobolis; Frank M Faraci
Journal:  Hypertension       Date:  2010-03-01       Impact factor: 10.190

7.  Cyclooxygenase 1-derived prostaglandin E2 and EP1 receptors are required for the cerebrovascular dysfunction induced by angiotensin II.

Authors:  Carmen Capone; Giuseppe Faraco; Josef Anrather; Ping Zhou; Costantino Iadecola
Journal:  Hypertension       Date:  2010-03-01       Impact factor: 10.190

8.  Gender influences cerebral vascular responses to angiotensin II through Nox2-derived reactive oxygen species.

Authors:  T Michael De Silva; Brad R S Broughton; Grant R Drummond; Christopher G Sobey; Alyson A Miller
Journal:  Stroke       Date:  2009-02-10       Impact factor: 7.914

9.  Role of oxidative stress and AT1 receptors in cerebral vascular dysfunction with aging.

Authors:  Mary L Modrick; Sean P Didion; Curt D Sigmund; Frank M Faraci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-04-24       Impact factor: 4.733

Review 10.  Oxidative stress and endothelial dysfunction in cerebrovascular disease.

Authors:  Sophocles Chrissobolis; Alyson A Miller; Grant R Drummond; Barbara K Kemp-Harper; Christopher G Sobey
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01
View more
  42 in total

1.  Transcriptional and phenotypic changes in aorta and aortic valve with aging and MnSOD deficiency in mice.

Authors:  Carolyn M Roos; Michael Hagler; Bin Zhang; Elise A Oehler; Arman Arghami; Jordan D Miller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-30       Impact factor: 4.733

2.  Protective effect of salidroside on contrast-induced nephropathy in comparison with N-acetylcysteine and its underlying mechanism.

Authors:  Yue Xing; Ri-bao Wei; Lu Tang; Yue Yang; Xiao-yong Zheng; Zi-cheng Wang; Yu-wei Gao
Journal:  Chin J Integr Med       Date:  2015-04-16       Impact factor: 1.978

3.  Augmented astrocyte microdomain Ca2+ dynamics and parenchymal arteriole tone in angiotensin II-infused hypertensive mice.

Authors:  Juan Ramiro Diaz; Ki Jung Kim; Michael W Brands; Jessica A Filosa
Journal:  Glia       Date:  2018-12-02       Impact factor: 7.452

Review 4.  Mechanisms of neurovascular dysfunction in acute ischemic brain.

Authors:  Y Terasaki; Y Liu; K Hayakawa; L D Pham; E H Lo; X Ji; K Arai
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

5.  Context-dependent effects of SOCS3 in angiotensin II-induced vascular dysfunction and hypertension in mice: mechanisms and role of bone marrow-derived cells.

Authors:  Ying Li; Dale A Kinzenbaw; Mary L Modrick; Lecia L Pewe; Frank M Faraci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-22       Impact factor: 4.733

Review 6.  Emerging molecular mechanisms of vascular dementia.

Authors:  Milagros C Romay; Camilo Toro; M Luisa Iruela-Arispe
Journal:  Curr Opin Hematol       Date:  2019-05       Impact factor: 3.284

7.  Chronic aldosterone administration causes Nox2-mediated increases in reactive oxygen species production and endothelial dysfunction in the cerebral circulation.

Authors:  Sophocles Chrissobolis; Grant R Drummond; Frank M Faraci; Christopher G Sobey
Journal:  J Hypertens       Date:  2014-09       Impact factor: 4.844

8.  Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer's disease.

Authors:  Anna Csiszar; Stefano Tarantini; Gábor A Fülöp; Tamas Kiss; M Noa Valcarcel-Ares; Veronica Galvan; Zoltan Ungvari; Andriy Yabluchanskiy
Journal:  Geroscience       Date:  2017-08-29       Impact factor: 7.713

9.  α-Lipoic acid reduces neurogenic hypertension by blunting oxidative stress-mediated increase in ADAM17.

Authors:  Thyago M de Queiroz; Huijing Xia; Catalin M Filipeanu; Valdir A Braga; Eric Lazartigues
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-07       Impact factor: 4.733

Review 10.  Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical research.

Authors:  Augusto C Montezano; Rhian M Touyz
Journal:  Antioxid Redox Signal       Date:  2013-06-06       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.